Publications

• Trans-differentiation of plasma cell neoplasm to acute myeloid leukemia with monocytic features: Case report of divergent phenotype with identical genotype.
  Leuk Res Rep Volume: 23 Page(s): 100504
  01/01/2025 Authors: Asakrah S; Deeb KK; Papadantonakis N; Deeb G
• Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines.
  Cytometry B Clin Cytom
  08/21/2024 Authors: Monaghan SA; Eck S; Bunting S; Dong XX; Durso RJ; Gonneau C; Hays A; Illingworth A; League SC; Linskens E
• Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives.
  Cancers (Basel) Volume: 16
  04/15/2024 Authors: Zhang L; Deeb G; Deeb KK; Vale C; Peker Barclift D; Papadantonakis N
• Plasmablastic transformation of chronic lymphocytic leukemia: a review of literature and report on 2 cases.
  Lab Med Volume: 54 Page(s): e177 - e185
  11/02/2023 Authors: Khanna A; Drumheller BR; Deeb G; Tolbert EW; Asakrah S
• A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma.
  Clin Lymphoma Myeloma Leuk Volume: 18 Page(s): e51 - e60
  01/01/2018 Authors: Torka P; Patel P; Tan W; Wilding G; Bhat SA; Czuczman MS; Lee KP; Deeb G; Neppalli V; Mavis C
• TAFRO syndrome: A case report and review of the literature.
  Hum Pathol (N Y) Volume: 10 Page(s): 1 - 4
  11/01/2017 Authors: Hou T; Dhillon J; Xiao W; Jaffe ES; Sands AM; Neppalli V; Deeb G; Zhang N
• Multimodality Technologies in the Assessment of Hematolymphoid Neoplasms.
  Arch Pathol Lab Med Volume: 141 Page(s): 341 - 354
  03/01/2017 Authors: Li S; Jaye DL; Bradley KT; Zhang L; Saxe D; Deeb G; Hill CE; Mann KP
• Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML.
  Case Rep Hematol Volume: 2016 Page(s): 1259759
  01/01/2016 Authors: Vachhani P; Mendler JH; Evans A; Deeb G; Starostik P; Wallace PK; Wang ES
• Augmenting Neutrophil Function By Administration of Peg-Filgrastim Potentiates Rituximab and Is Safe in Patients with Indolent B-Cell Non-Hodgkin Lymphomas: Results of a Phase II Study
  Volume: 126
  12/03/2015 Authors: Torka P; Patel PP; Tan W; Wilding G; Bhat SA; Czuczman MS; Lee KP; Deeb G; Neppalli VT; Mavis C
• Autologous reconstitution leading to sustained JAK2-V617F negativity post allogeneic hematopoietic stem cell transplant in JAK2-V617F positive myelofibrosis.
  Bone Marrow Transplant Volume: 50 Page(s): 1480 - 1482
  11/01/2015 Authors: Torka P; Hahn T; Bertolo J; Liu H; Ross M; Paplham P; Jankowski A; Deeb G; Chen G; McCarthy P
• Anaplastic Plasma Cell Myeloma with Features Mimicking Angiosarcoma: A Case Report
  AMERICAN JOURNAL OF CLINICAL PATHOLOGY Volume: 144 Page(s): A118 - A118
  10/01/2015 Authors: Zhang L; Nakhla H; Balos L; Deeb G; Sands A; Liu W
• Impact of clinical parameters on surgical outcomes in patients with hematological disorders undergoing splenectomy.
  Volume: 33
  05/20/2015 Authors: Torka P; Hernandez-Ilizaliturri FJ; Bhat SA; Czuczman MS; Basra P; Kuvshinoff BW; Deeb G; Skitzki JJ; Neppalli V
• Case study interpretation--Fort Lauderdale: Case 3.
  Cytometry B Clin Cytom Volume: 88 Page(s): 404 - 407
  01/01/2015 Authors: Deeb G; Wang E; Wallace P
• Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study
  Volume: 124
  12/06/2014 Authors: Merzianu M; Cheney R; Groman A; Deeb G; Wilding G; Cotta C; Amre R; Balasubramanian M; Brandao G; Brynes RK
• Intense Cytarabine-Based Chemo-Immunotherapy, Central Nervous System (CNS) Prophylaxis and Early High-Dose Chemotherapy and Autologous Stem Cell Support (HDC-ASCS) in First Remission Are Associated with an Improved Clinical Outcome in Double-Hit (DHL)/Triple-Hit (THL) Diffuse Large B-Cell Lymphoma (DLBCL)
  Volume: 124
  12/06/2014 Authors: Patel PP; Torka P; Neppalli VT; Deeb G; Sait SNJ; Block AW; Bhat SA; Czuczman MS; Hernandez-Ilizaliturri FJ
• Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.
  Biol Blood Marrow Transplant Volume: 20 Page(s): 1369 - 1374
  09/01/2014 Authors: Chen GL; Liu H; Zhang Y; Thomas J; Ross M; Wang ES; Block AW; Sait S; Deeb G; Wallace P
• Clinicopathologic Characteristics of Adult Acute Leukemia with t(4;11)(q21;q23) [MLLT2 (AF4)-MLL]
  Volume: 94 Page(s): 334A - 335A
  02/01/2014 Authors: Baqai J; Neppalli V; Sait S; Wallace P; Deeb G
• Clinicopathologic Characteristics of Adult Acute Leukemia with t(4;11)(q21; q23) [MLLT2(AF4)-MLL]
  Volume: 27 Page(s): 334A - 335A
  02/01/2014 Authors: Baqai J; Neppalli V; Sait S; Wallace P; Deeb G
• Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemia.
  Leuk Res Rep Volume: 3 Page(s): 86 - 89
  01/01/2014 Authors: Deeb KK; Smonskey MT; DeFedericis H; Deeb G; Sait SNJ; Wetzler M; Wang ES; Starostik P
• Case Study Interpretation-Fort Lauderdale: Case 3.
  Cytometry B Clin Cytom
  12/14/2013 Authors: Deeb G; Wang E; Wallace P
• MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models.
  Anticancer Drugs Volume: 24 Page(s): 1030 - 1038
  11/01/2013 Authors: Gu JJ; Hernandez-Ilizaliturri FJ; Mavis C; Czuczman NM; Deeb G; Gibbs J; Skitzki JJ; Patil R; Czuczman MS
• Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age.
  Leuk Res Volume: 37 Page(s): 1468 - 1471
  11/01/2013 Authors: Vigil CE; Tan W; Deeb G; Sait SN; Block AW; Starostik P; Griffiths EA; Thompson JE; Greene JD; Ford LA
• CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations.
  Leuk Lymphoma Volume: 54 Page(s): 1517 - 1520
  07/01/2013 Authors: Francis J; Dharmadhikari AV; Sait SNJ; Deeb G; Wallace PK; Thompson JE; Wang ES; Wetzler M
• MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma.
  Leukemia Volume: 27 Page(s): 1381 - 1390
  06/01/2013 Authors: Wenzel S-S; Grau M; Mavis C; Hailfinger S; Wolf A; Madle H; Deeb G; Drken B; Thome M; Lenz P
• MCL1 is deregulated and mediates therapy resistance in subgroups of diffuse large B-cell lymphoma
  ONKOLOGIE Volume: 35 Page(s): 105 - 105
  10/01/2012 Authors: Wenzel S-S; Grau M; Mavis C; Hailfinger S; Wolf A; Madle H; Deeb G; Doerken B; Thome M; Lenz P
• Predicting outcome based on minimal residual disease (MRD) using multiparameter flow cytometry (FC) in acute myeloid leukemia (AML) patients (Pts)
  Volume: 30
  05/20/2012 Authors: Sardesai SD; Tan W; Ford LA; Deeb G; Block AMW; Sait SNJ; McCarthy PL; Vigil CE; Griffiths EA; Thompson JE
• Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
  Am J Clin Pathol Volume: 137 Page(s): 641 - 646
  04/01/2012 Authors: Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
• Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma.
  Br J Haematol Volume: 156 Page(s): 490 - 498
  02/01/2012 Authors: Barth MJ; Hernandez-Ilizaliturri FJ; Mavis C; Tsai P-C; Gibbs JF; Deeb G; Czuczman MS
• Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.
  Cancer Volume: 117 Page(s): 5058 - 5066
  11/15/2011 Authors: Hernandez-Ilizaliturri FJ; Deeb G; Zinzani PL; Pileri SA; Malik F; Macon WR; Goy A; Witzig TE; Czuczman MS
• Intracranial meningiomas in patients with uterine sarcoma treated with long-term megestrol acetate therapy.
  World Neurosurg Volume: 76 Page(s): 477.e16 - 477.e20
  11/01/2011 Authors: Gruber TJ; Fabiano AJ; Deeb G; Lele SB; Fenstermaker RA
• Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.
  Br J Haematol Volume: 153 Page(s): 599 - 611
  06/01/2011 Authors: Brem EA; Thudium K; Khubchandani S; Tsai P-C; Olejniczak SH; Bhat S; Riaz W; Gu J; Iqbal A; Campagna R
• Association of IDH1 mutations in normal karyotype acute myeloid leukemia samples with higher HIF-1 alpha and VEGF-A expression
  JOURNAL OF CLINICAL ONCOLOGY Volume: 29
  05/20/2011 Authors: Smonskey M; Starostik P; Deeb G; Demock K; Vargas R; Lal D; Sait SN; Wetzler M; Wang ES
• Association of IDH1 mutations in normal karyotype acute myeloid leukemia samples with higher HIF-1 and VEGF-A expression.
  J Clin Oncol Volume: 29 Page(s): 6530
  05/20/2011 Authors: Smonskey M; Starostik P; Deeb G; Demock K; Vargas R; Lal D; Sait SN; Wetzler M; Wang ES
• Hypoxia-inducible factor-1 protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia.
  Leuk Res Volume: 35 Page(s): 579 - 584
  05/01/2011 Authors: Deeb G; Vaughan MM; McInnis I; Ford LA; Sait SNJ; Starostik P; Wetzler M; Mashtare T; Wang ES
• MLN2238, a Novel and Potent Proteasome Inhibitor, Induces Caspase-Dependent Cell Death, Cell-Cycle Arrest, and Potentiates the Anti-Tumor Activity of Chemotherapy Agents In Rituximab-Chemotherapy Sensitive or Resistant B-Cell Lymphoma Cell Lines
  Volume: 116 Page(s): 1606 - 1606
  11/19/2010 Authors: Gu J; Ritesh P; Mavis C; Deeb G; Gibbs J; Hernandez-Ilizaliturri FJ; Czuczman MS
• Ofatumumab, a Fully Human Monoclonal Antibody Targeting CD20, Demonstrates Activity Against and Potentiates the Anti-Tumor Activity of Chemotherapy Agents In Rituximab-Sensitive Cell Lines (RSCL), Rituximab-Resistant Cell Lines (RRCL), Lymphoma Xenografts, and Primary Tumor Cells Derived From Patients with B-Cell Non-Hodgkin Lymphoma (NHL)
  Volume: 116 Page(s): 1598 - 1598
  11/19/2010 Authors: Barth M; Hernandez-Ilizaliturri FJ; Mavis C; Tsai P-C; Gibbs J; Deeb G; Czuczman MS
• Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
  Cancer Genet Cytogenet Volume: 202 Page(s): 101 - 107
  10/15/2010 Authors: Wang ES; Sait SNJ; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
• Comparative Assessment of Zinc-Based Fixatives in Hematopathology Practice
  Volume: 134 Page(s): 680 - 680
  10/01/2010 Authors: Malik DA; Starostik P; Deeb G; Risch N; Barcos M; Merzianu M
• Plasma cell leukaemia and other aggressive plasma cell malignancies.
  Br J Haematol Volume: 150 Page(s): 418 - 427
  08/01/2010 Authors: Sher T; Miller KC; Deeb G; Lee K; Chanan-Khan A
• Response of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) with nongerminal center B-cell phenotype to lenalidomide (L) alone or in combination with rituximab (R)
  Volume: 28
  05/20/2010 Authors: Hernandez-Ilizaliturri FJ; Deeb G; Zinzani PL; Pileri SA; Malik F; Macon WR; Witzig TE; Goy A; Czuczman MS
• The role of FLT3 in sole trisomy 8 acute myeloid leukemia
  JOURNAL OF CLINICAL ONCOLOGY Volume: 28
  05/20/2010 Authors: Block AW; Groman AE; Wilding GE; Ford L; Sait SN; Deeb G; Starostik P; Wang ES; Thompson JE; Wetzler M
• Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia.
  Cancer Genet Cytogenet Volume: 199 Page(s): 15 - 20
  05/01/2010 Authors: Nowak NJ; Sait SNJ; Zeidan A; Deeb G; Gaile D; Liu S; Ford L; Wallace PK; Wang ES; Wetzler M
• Diverse Roles of Hepatocyte Growth Factor (HGF) in Normal Karyotype Acute Myeloid Leukemia (AML)
  Volume: 114 Page(s): 1208 - 1208
  11/20/2009 Authors: McInnis I; Hahn T; Ioane A; Larnson A; Lal D; Ford LA; Sait SNJ; Starostik P; Deeb G; Wetzler M
• Fatal hyperacute graft-versus-host disease following denileukin diftitox treatment for recurrent t cell lymphoma after allogeneic stem cell transplantation.
  Biol Blood Marrow Transplant Volume: 15 Page(s): 887 - 890
  07/01/2009 Authors: Khubchandani S; Deeb G; Smiley SL; Battiwalla M; Paplham P; Brown K; Syta M; Hahn T; Cheney R; McCarthy PL
• Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report.
  Cancer Chemother Pharmacol Volume: 64 Page(s): 177 - 181
  06/01/2009 Authors: Bharthuar A; Egloff L; Becker J; George M; Lohr JW; Deeb G; Iyer RV
• Expression of Vascular Endothelial Growth Factor Receptors VEGFR-1 and VEGFR-2 Are Prognostic Factors in Normal Karyotype Acute Myeloid Leukemia (NK-AML).
  Volume: 112 Page(s): 886 - 887
  11/16/2008 Authors: Demock KM; Marinaro J; Sobczyk A; Ford LA; Wetzler M; Deeb G; Tian L; Wang ES
• Hypoxia-Inducible Factor-1 Alpha (HIF-1 alpha) and HIF-2 alpha Are Independent Prognostic Factors for Normal Karyotype Acute Myeloid Leukemia (NK AML).
  Volume: 112 Page(s): 887 - 887
  11/16/2008 Authors: Demock KM; Marinaro J; McInnis I; Ford LA; Wetzler M; Tian L; Deeb G; Wang ES
• Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo.
  Br J Haematol Volume: 140 Page(s): 36 - 45
  01/01/2008 Authors: Reddy N; Hernandez-Ilizaliturri FJ; Deeb G; Roth M; Vaughn M; Knight J; Wallace P; Czuczman MS
• CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma.
  Leuk Lymphoma Volume: 48 Page(s): 2424 - 2436
  12/01/2007 Authors: Cruz RI; Hernandez-Ilizaliturri FJ; Olejniczak S; Deeb G; Knight J; Wallace P; Thurberg BL; Kennedy W; Czuczman MS
• VEGF-A, VEGF-C, and CD31 expression by leukemia cells are prognostic factors for overall survival in acute myeloid leukemia (AML)
  Volume: 110 Page(s): 706A - 706A
  11/16/2007 Authors: Wang ES; Sobczyk A; Marinaro JM; Wetzler M; Tian L; Deeb G
• Frequent molecular aberrations in normal karyotype (NC) precursor B-cell acute lymphoblastic leukemia (pB-ALL) detected by comparative genomic hybridization
  Volume: 110 Page(s): 135B - 135B
  11/16/2007 Authors: Zeidan A; Gaile D; Conroy JM; McQuaid DE; Wang ES; Deeb G; Wallace PK; Sait SNJ; Nowak NJ; Wetzler M
• Genomic profiling of myeloid sarcoma by array comparative genomic hybridization.
  Genes Chromosomes Cancer Volume: 44 Page(s): 373 - 383
  12/01/2005 Authors: Deeb G; Baer MR; Gaile DP; Sait SNJ; Barcos M; Wetzler M; Conroy JM; Nowak NJ; Cowell JK; Cheney RT
• A rare female genital tract tumor: benign granular cell tumor of vulva: case report and review of the literature.
  Gynecol Oncol Volume: 97 Page(s): 656 - 658
  05/01/2005 Authors: Cheewakriangkrai C; Sharma S; Deeb G; Lele S
• Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.
  Int J Mol Med Volume: 14 Page(s): 43 - 53
  07/01/2004 Authors: Collins Y; Tan DF; Pejovic T; Mor G; Qian F; Rutherford T; Varma R; McQuaid D; Driscoll D; Jiang M
• Lipomatous hemangiopericytoma of the head and neck: immunohistochemical and DNA ploidy analyses.
  Head Neck Volume: 26 Page(s): 544 - 549
  06/01/2004 Authors: Alrawi SJ; Deeb G; Cheney R; Wallace P; Loree T; Rigual N; Hicks W; Tan D
• Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry.
  Volume: 17 Page(s): 430 - 439
  04/01/2004 Authors: Deeb G; Wang J; Ramnath N; Slocum HK; Wiseman S; Beck A; Tan D
• Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients.
  Am J Clin Pathol Volume: 121 Page(s): 512 - 525
  04/01/2004 Authors: Kansal R; Deeb G; Barcos M; Wetzler M; Brecher ML; Block AW; Stewart CC
• HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
  Diagn Mol Pathol Volume: 12 Page(s): 201 - 211
  12/01/2003 Authors: Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C
• Pathologic quiz case: a cystic breast mass. Cystic hypersecretory hyperplasia with cytologic atypia.
  Arch Pathol Lab Med Volume: 127 Page(s): e389 - e390
  09/01/2003 Authors: Zhao X-F; Deeb G; Tan D-F
• Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
  Hum Pathol Volume: 34 Page(s): 597 - 604
  06/01/2003 Authors: Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
• CD138 (Syndecan-1) in lymphoid neoplasms: A paraffin immunohistochemical (IHC) study with flow cytometry (FC) correlation
  Volume: 83 Page(s): 229A - 229A
  01/01/2003 Authors: Deeb G; Kansal R; Stewart CC; Barcos M
• A high-density tissue microarray(TMA) and immunohistochemistry(IHC) study of thyroid transcription factor-1 (TTF-1) expression in non-small-cell lung cancer(NSCLC)
  Volume: 83 Page(s): 314A - 314A
  01/01/2003 Authors: Tan DF; Li Q; Deeb G; Slocum HK; Ramnath N; Loewen G; Wiseman S; Brooks JJ
• A high-density tissue microarray(TMA) and immunohistochemistry(IHC) study of thyroid transcription Factor-1(TTY-1) expression in non-small-cell lung cancer(NSCLC)
  Volume: 16 Page(s): 314A - 314A
  01/01/2003 Authors: Tan DF; Li Q; Deeb G; Slocum HK; Ramnath N; Loewen G; Wiseman S; Brooks JJ
• CD138 (syndecan-1) in lymphoid neoplasms: A paraffin immunohistochemical (IHC) study with flow cytometry (FC) correlation
  Volume: 16 Page(s): 229A - 229A
  01/01/2003 Authors: Deeb G; Kansal R; Stewart CC; Barcos M
• Precursor B-cell acute lymphoblastic leukemia with surface light chain immunoglobulin restriction: A report of 12 patients
  MODERN PATHOLOGY Volume: 15 Page(s): 237A - 237A
  01/01/2002 Authors: Deeb G; Kansal R; Barcos M; Block AMW; Stewart CC
• Precursor B-cell acute lymphoblastic leukemia with surface light chain immunoglobulin restriction: A report of 12 patients
  LABORATORY INVESTIGATION Volume: 82 Page(s): 237A - 237A
  01/01/2002 Authors: Deeb G; Kansal R; Barcos M; Block AMW; Stewart CC
• Monoclonal antibody clone and fluorochrome intensity affect detection of CD19 expression on t(8;21) AML.
  BLOOD Volume: 98 Page(s): 185B - 185B
  11/16/2001 Authors: Block AW; Deeb G; Barcos M; Stewart CC